Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections effectively promote hair growth in androgenetic alopecia patients.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Finasteride increases hair weight and count in men with hair loss, with best results after four years.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.